3858 results for «2286»
3858 results
Aortic regurgitation - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to gain valuable knowledge on approaches to address aortic regurgitation: uncover the clinical effectiveness of TAVR in managing aortic insufficiency associated with LVAD and delve into the comparison between echocardiography and magnetic resonance imaging for assessing device regurgitation in patients undergoing TAVI.
Rare complications of structural intervention
21 Nov 2023 – From PCR London Valves 2023
Join us in this session for a look at rare and challenging scenarios in structural interventions: delve into the complexities of an ascending aorta mycotic aneurysm in a patient with a prior TAVI procedure, witness a unique case showcasing a misloaded self-expanding TAVR device, uncover the...
TAVI outcomes - Part 2
21 Nov 2023 – From PCR London Valves 2023
Explore the latest insights in TAVI outcomes with this session: delve into the pursuit of transatlantic harmonization in echocardiography core laboratory analysis and adjudication according to VARC3 guidelines, investigate the nuances of TAV deployment within an elliptical aortic root, uncover the clinical impact of multiple resheathing...
TAVI - Vascular complications
21 Nov 2023 – From PCR London Valves 2023
Learn valuable insights into vascular complications management and prevention during TAVI with this session: navigate the challenges of a post-TAVI common femoral artery occlusion in a patient with a previously implanted bioabsorbable closure device, witness the difficulties of common iliac artery stent dislodgment, explore the rare...
TAVI - complications
21 Nov 2023 – From PCR London Valves 2023
Because TAVI is not without risk, learn about bailout endovascular techniques to counter transcatheter aortic valve LV dislocation, analyze the cost of infectious complications caused by TAVR compared with SAVR, and discover how imaging can predict aortic root rupture or conduction abnormalities, among others.
Coronary imaging in the structural cathlab
21 Nov 2023 – From PCR London Valves 2023
If you still have any doubts, take a look at the presentations in this PCR LV 2023 session to be convinced of the importance of imaging, particularly IVUS, pre-, during and post-TAVI! It helps to prevent coronary artery occlusions, manage post-TAVR complications and guide rotablation, to name...
Mitral valve interventions in challenging clinical situations
21 Nov 2023 – From PCR London Valves 2023
Discover innovative approaches to mitral valve interventions in challenging clinical situations: navigate the challenges of critical stenosis in a bioprosthetic mitral valve, learn more about the use of iVAC-2L in transcatheter edge-to-edge repair for a mitral valve lacking leaflet coaptation, explore mitral transcutaneous edge-to-edge repair guided by transthoracic...
Second time TAVI (TAV-in-TAV) - Not as simple as it looks
19 Nov 2023 – From PCR London Valves 2023
Although it is still rare, TAV-in-TAV is likely to become more frequent, as TAVI is increasingly implanted in younger patients. Harmonizing data in this area will therefore help to improve outcomes, the quality of which depends on site experience, bearing in mind that for the time...
TAVI - Coronary access
21 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI and coronary access with this session: explore the use of IVUS in assessing coronary arteries at high risk for obstruction following valve-in-valve TAVI, witness the application of patient-specific computer simulation to predict coronary re-access post-TAVI in bicuspid anatomy, navigate the...
Don't forget the nurses and allied professionals when introducing new technology!
19 Nov 2023 – From PCR London Valves 2023
Learn all you need to know about adopting new technology, bearing in mind that both trainer and trainee share learning responsibilities and that focus should be on collaboration with industry and variety of teaching methods.
Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?
19 Nov 2023 – From PCR London Valves 2023
Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!
TAVI durability and potential future solutions - LIVE case
19 Nov 2023 – From PCR London Valves 2023
In this session, you will learn more about the potential technical challenges associated with second-time TAVI procedures, and the importance of detailed CT imaging and careful pre-procedural planning. Discover the latest innovations and future direction of this key area of development.
- Live case: An 83-year-old woman with type 2 diabetes, COPD...
Key questions in mitral valve intervention - Transcatheter edge-to-edge repair (Part 1) - what do I need to know to do the procedure safely?
19 Nov 2023 – From PCR London Valves 2023
Analyze in depth the case of a 64-year-old female patient with ischaemic cardiomyopathy with LVEF 40 % and severe ventricular mitral regurgitation, who previously had NSTE-ACS treated with LAD and circumflex PCI, and who presented with recent worsening heart failure and persistent NYHA class II-III, and...
Lifetime management for the valve patient
20 Nov 2023 – From PCR London Valves 2023
This session focuses on acquiring the necessary knowledge for engaging in discussions with patients about the lifelong management of valve disease. It emphasizes understanding the relevance of life expectancy and comorbidities, as well as providing key information to support shared decision-making between healthcare professionals and patients.
Mitral edge-to-edge repair using advanced imaging techniques
20 Nov 2023 – From PCR London Valves 2023
Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach
20 Nov 2023 – From PCR London Valves 2023
This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...
TAVI in complex scenarios - Prevention and management of acute coronary obstruction
20 Nov 2023 – From PCR London Valves 2023
Although acute coronary obstruction remains rare, it is a dramatic complication during TAVI: find out how to predict this preventable obstruction in different clinical scenarios by learning the key steps of the chimney stenting and BASILICA techniques, and get a glimpse into the future to learn...
Rapid-fire - Nightmares in the cathlab - Part 1
19 Nov 2023 – From PCR London Valves 2023
Discover intriguing cases featured in the PCR London Valves 2023 course: learn about a rare malfunction in a Mitral TEER device, delve into the complexities surrounding a self-expanding valve TAVI where embolisation poses a threat towards the left ventricle, explore the challenges associated with TAVR in...
Rapid-fire - Challenging TAVI procedures - Part 1
19 Nov 2023 – From PCR London Valves 2023
Discover challenging TAVI procedures in this session, including: TAVI in a small aortic annulus with chimney stenting, TAVI with ACURATE Neo 2 and coronary protection in a horizontal aorta with low coronary height, simultaneous kissing balloon inflation technique for effective coronary protection during TAVI, and much...
Complex transcatheter mitral and tricuspid interventions - Recorded cases
20 Nov 2023 – From PCR London Valves 2023
This session features two compelling cases of percutaneous annuloplasty for advanced heart failure and massive tricuspid regurgitation:
- Left ventricular restoration in heart failure with reduced ejection fraction
A 56-year-old male, with type 2 diabetes, hypertension and chronic kidney disease, presented a symptomatic severe LV dysfunction (26%) and severely...
